Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

RPRX

Royalty Pharma plc

Sep 15 • 12:38PM ET

35.06

-1.30 -3.56 %

Healthcare • Biotechnology • USA • NASD

Peers: BIIB REGN VRTX GILD INCY ALNY EXEL NBIX MDGL DKNG

| Held by: VTI VO VXF VFLO VTV VOE VYM IWR VHT SCHM

Scroll to Statements

Index	-	P/E	15.27	EPS (ttm)	2.30	Insider Own	21.19%	Shs Outstand	432.29M	Perf Week	-2.05%
Market Cap	15.16B	Forward P/E	6.96	EPS next Y	5.04	Insider Trans	-0.04%	Shs Float	340.69M	Perf Month	-3.93%
Enterprise Value	25.69B	PEG	1.43	EPS next Q	1.04	Inst Own	80.48%	Short Float	4.88%	Perf Quarter	0.65%
Income	1.02B	P/S	6.57	EPS this Y	8.40%	Inst Trans	4.29%	Short Ratio	4.69	Perf Half Y	7.00%
Sales	2.31B	P/B	2.39	EPS next Y	12.63%	ROA	5.67%	Short Interest	16.62M	Perf YTD	37.46%
Book/sh	14.68	P/C	23.50	EPS next 5Y	10.69%	ROE	15.92%	52W High	38.00 -7.72%	Perf Year	26.22%
Cash/sh	1.49	P/FCF	6.01	EPS past 3/5Y	8.57% -21.51%	ROIC	7.63%	52W Low	24.05 45.80%	Perf 3Y	-18.43%
Dividend Est.	0.92 (2.63%)	EV/EBITDA	13.96	Sales past 3/5Y	-0.38% 4.52%	Gross Margin	-	Volatility	2.85% 2.20%	Perf 5Y	-10.18%
Dividend TTM	0.87 (2.48%)	EV/Sales	11.14	EPS Y/Y TTM	53.03%	Oper. Margin	79.81%	ATR (14)	0.87	Perf 10Y	-
Dividend Ex-Date	Aug 15, 2025	Quick Ratio	1.26	Sales Y/Y TTM	3.04%	Profit Margin	44.26%	RSI (14)	40.24	Recom	1.50
Dividend Gr. 3/5Y	7.30% -	Current Ratio	1.26	EPS Q/Q	-68.63%	SMA20	-3.06%	Beta	0.59	Target Price	44.50
Payout	43.94%	Debt/Eq	1.26	Sales Q/Q	7.71%	SMA50	-3.51%	Rel Volume	1.05	Prev Close	36.36
Employees	99	LT Debt/Eq	1.11	Earnings	Aug 06 BMO	SMA200	7.54%	Avg Volume	3.54M	Price	35.06
IPO	Jun 16, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.53% 4.95%	Trades		Volume	1,890,381	Change	-3.56%

Date	Action	Analyst	Rating Change	Price Target Change
May-16-25	Initiated	Morgan Stanley	Overweight	$51
Jun-03-24	Downgrade	UBS	Buy → Neutral	$28
Jun-14-22	Resumed	UBS	Buy	$47
May-13-22	Initiated	Scotiabank	Sector Outperform	$53
Apr-27-22	Initiated	Goldman	Buy	$56
Apr-14-22	Upgrade	JP Morgan	Neutral → Overweight	$50
Apr-06-22	Resumed	Morgan Stanley	Overweight	$48
Oct-29-21	Upgrade	Citigroup	Neutral → Buy	$50
Jul-30-21	Initiated	Tigress Financial	Buy	$50
Nov-09-20	Upgrade	UBS	Neutral → Buy	$52 → $51
Jul-14-20	Initiated	Evercore ISI	In-line
Jul-13-20	Initiated	UBS	Neutral	$52
Jul-13-20	Initiated	SunTrust	Buy	$56
Jul-13-20	Initiated	Morgan Stanley	Equal-Weight	$51
Jul-13-20	Initiated	JP Morgan	Neutral	$50
Jul-13-20	Initiated	Goldman	Neutral	$47
Jul-13-20	Initiated	Cowen	Outperform	$55
Jul-13-20	Initiated	Citigroup	Neutral	$50
Jul-13-20	Initiated	BofA Securities	Buy	$55

Show Previous Ratings

Sep-11-25 11:13AM	Royalty Pharma plc (RPRX) Commits $300M to Zenas' Obexelimab Program (Insider Monkey)
07:00AM	Royalty Pharma Investor Day Highlights Strong Growth Outlook and Company's Plans to Drive Value Creation (GlobeNewswire)
Sep-10-25 07:30AM	Royalty Pharma Announces Release of Deloitte's Report on the Biopharma Royalty Market (GlobeNewswire)
Sep-04-25 04:15PM	Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference (GlobeNewswire)
Sep-02-25 08:30PM	Royalty Pharma Announces Pricing of $2.0 Billion of Senior Unsecured Notes (GlobeNewswire)
07:15AM	Loading…
07:15AM	Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million (GlobeNewswire)
Aug-29-25 02:57PM	Royalty Pharma (RPRX) Strengthens Pipeline With New Oncology Royalty Purchase (Insider Monkey)
05:05AM	Royalty Pharma plc (RPRX) Boosts Growth with $885M Amgen Imdelltra Royalty Deal (Insider Monkey)
04:54AM	Royalty Pharma plc (RPRX) Strikes $2B Partnership with Revolution Medicines (Insider Monkey)
Aug-25-25 01:19PM	BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up (Benzinga)
08:29AM	Royalty Pharma buys BeOne stake in Amgen lung cancer drug sales (BioPharma Dive)
06:33AM	Royalty Pharma to pay up to $950 million for royalties from Amgen's lung cancer drug (Reuters)
06:10AM	Royalty Pharma to Acquire Royalty Interest in Amgen's Imdelltra for up to $950 Million (GlobeNewswire)
06:00AM	BeOne Medicines Announces IMDELLTRA Royalty Purchase Agreement for up to $950 Million (Business Wire)
Aug-13-25 04:15PM	Henry Fernandez Steps Down from Royalty Pharma's Board of Directors (GlobeNewswire)
01:35AM	Loading…
01:35AM	5 Insightful Analyst Questions From Royalty Pharma's Q2 Earnings Call (StockStory)
Aug-12-25 09:10AM	Morgan Stanley Maintains a Buy Rating on Royalty Pharma Plc (RPRX) With a $55 PT (Insider Monkey)
03:18AM	RPRX Q2 Deep Dive: Margins Compress Despite Solid Royalty Growth and Strategic Investments (StockStory)
Aug-10-25 11:31PM	Reflecting On Branded Pharmaceuticals Stocks' Q2 Earnings: Royalty Pharma (NASDAQ:RPRX) (StockStory)
Aug-06-25 05:45PM	Analyst Report: Royalty Pharma plc (Morningstar Research)
04:02PM	Revolution Medicines Reports Second Quarter 2025 Financial Results and Update on Corporate Progress (GlobeNewswire)
09:30AM	Here's What Key Metrics Tell Us About Royalty Pharma (RPRX) Q2 Earnings (Zacks)
08:20AM	Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates (Zacks)
08:08AM	Royalty Pharma (NASDAQ:RPRX) Misses Q2 Revenue Estimates (StockStory)
07:22AM	Royalty Pharma: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Royalty Pharma Reports Second Quarter 2025 Results (GlobeNewswire)
Aug-05-25 09:15AM	Countdown to Royalty Pharma (RPRX) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Aug-04-25 11:21PM	Earnings To Watch: Royalty Pharma (RPRX) Reports Q2 Results Tomorrow (StockStory)
Jul-30-25 10:00AM	Royalty Pharma (RPRX) Earnings Expected to Grow: Should You Buy? (Zacks)
12:02AM	2 Reasons to Watch RPRX and 1 to Stay Cautious (StockStory)
08:15AM	Loading…
Jul-18-25 08:15AM	Royalty Pharma Declares Third Quarter 2025 Dividend (GlobeNewswire)
Jul-17-25 08:15AM	Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company's Board of Directors (GlobeNewswire)
Jul-16-25 04:15PM	Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025 (GlobeNewswire)
Jul-01-25 06:20AM	Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? (Zacks)
Jun-27-25 08:33AM	5 Revealing Analyst Questions From Royalty Pharma's Q1 Earnings Call (StockStory)
Jun-24-25 07:05AM	Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion (GlobeNewswire)
Jun-18-25 11:39PM	Q1 Rundown: Royalty Pharma (NASDAQ:RPRX) Vs Other Branded Pharmaceuticals Stocks (StockStory)
Jun-12-25 07:26PM	Analyst Report: Royalty Pharma plc (Morningstar Research)
Jun-09-25 09:54AM	RPRX Q1 Earnings Call: Flat Revenue, Portfolio Expansion, and Capital Return Initiatives (StockStory)
Jun-04-25 04:15PM	Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire)
May-16-25 04:30PM	Royalty Pharma Completes the Acquisition of Its External Manager (GlobeNewswire)
May-13-25 08:15AM	Royalty Pharma to Present at Upcoming Investor Conferences (GlobeNewswire)
May-12-25 04:15PM	Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition (GlobeNewswire)
May-08-25 08:03PM	Analyst Report: Royalty Pharma plc (Morningstar Research)
10:30AM	Royalty Pharma (RPRX) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
08:25AM	Royalty Pharma (RPRX) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:15AM	Royalty Pharma Reports First Quarter 2025 Results (GlobeNewswire)
May-07-25 12:34PM	Royalty Pharma Q1 2025 Earnings Preview (Seeking Alpha)
May-05-25 09:15AM	Unlocking Q1 Potential of Royalty Pharma (RPRX): Exploring Wall Street Estimates for Key Metrics (Zacks)
May-01-25 10:01AM	Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Apr-28-25 06:50PM	Alerus (ALRS) Q1 Earnings and Revenues Top Estimates (Zacks)
Apr-24-25 08:16AM	Royalty Pharma PLC (RPRX) Surged Following an Acquisition Announcement (Insider Monkey)
07:36AM	Thomas: Fragile is the word we agreed on (CNBC TV)
Apr-22-25 12:00PM	Patient Capital Management Q1 2025 Investment Review (Seeking Alpha)
11:20AM	Patient Capital Management Q1 2025 Commentary (Seeking Alpha)
Apr-21-25 04:15PM	Royalty Pharma Declares Second Quarter 2025 Dividend (GlobeNewswire)
Apr-17-25 04:15PM	Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025 (GlobeNewswire)
Apr-10-25 06:20AM	Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now? (Zacks)
Apr-08-25 04:15PM	Royalty Pharma Appoints Vlad Coric, M.D. to the Company's Board of Directors (GlobeNewswire)
Apr-02-25 09:47AM	Is Royalty Pharma plc (RPRX) The Most Profitable Biotech Stock To Buy Right Now? (Insider Monkey)
Apr-01-25 10:00AM	Is Royalty Pharma Plc (RPRX) the Most Undervalued Healthcare Stock to Buy According to Analysts? (Insider Monkey)
06:20AM	Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)? (Zacks)
Mar-29-25 07:15AM	4 Healthcare Stocks With Massive Gains-and More to Come (MarketBeat)
Mar-27-25 08:15AM	Royalty Pharma Announces Upcoming Investor Day (GlobeNewswire)
Mar-26-25 11:43AM	3 Reasons to Sell RPRX and 1 Stock to Buy Instead (StockStory) -6.52%
Mar-25-25 09:19PM	Is Royalty Pharma plc (RPRX) The Best Defensive Stock Amid Market Volatility? (Insider Monkey)
Mar-21-25 11:30AM	Why Is Blue Owl Capital Corporation (OBDC) Down 3% Since Last Earnings Report? (Zacks)
05:12AM	Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks (StockStory)
Feb-27-25 04:15PM	Royalty Pharma to Present at TD Cowen's 45th Annual Health Care Conference (GlobeNewswire)
Feb-23-25 03:03PM	Why Royalty Pharma Plc (RPRX) is the Best Performing Pharma Stock So Far in 2025 (Insider Monkey)
Feb-13-25 07:57PM	Analyst Report: Royalty Pharma plc (Morningstar Research)
Feb-12-25 09:06AM	Analyst Report: Royalty Pharma plc (Morningstar Research)
06:30AM	Royalty Pharma Announces R&D Funding Collaboration With Biogen (GlobeNewswire)
02:07AM	Royalty Pharma PLC (RPRX) Q4 2024 Earnings Call Highlights: Strong Financial Performance and ... (GuruFocus.com)
Feb-11-25 07:33AM	Royalty Pharma (NASDAQ:RPRX) Misses Q4 Revenue Estimates (StockStory)
07:15AM	Royalty Pharma Reports Q4 and Full Year 2024 Results (GlobeNewswire)
Feb-10-25 08:03AM	Royalty Pharma Earnings: What To Look For From RPRX (StockStory)
Jan-29-25 09:00AM	Royalty Pharma Announces Sale of MorphoSys Development Funding Bonds (GlobeNewswire)
Jan-28-25 04:15PM	Royalty Pharma to Announce Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025 (GlobeNewswire)
Jan-23-25 06:29AM	Why Is Andreas Halvorsen Bullish On Royalty Pharma plc (RPRX) Now? (Insider Monkey)
Jan-15-25 01:52PM	Royalty Pharma plc (RPRX): Analysts Recommend This 52-Week High Stocks Now (Insider Monkey)
Jan-12-25 11:24AM	Heres Why Royalty Pharma plc (RPRX) Led This Weeks Rally (Insider Monkey)
Jan-11-25 01:10PM	Did Royalty Pharma (RPRX) Close Shortened Trading Week Higher? (Insider Monkey)
Jan-10-25 07:30AM	Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +12.56%
07:15AM	Royalty Pharma Announces Transformative Step in Company's Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program (GlobeNewswire)
Jan-09-25 04:15PM	Royalty Pharma Announces Dividend Increase (GlobeNewswire)
Dec-27-24 05:47AM	Jim Cramer on Royalty Pharma plc (RPRX): Disappointing Stock, Man, I Cant Believe It (Insider Monkey)
Dec-24-24 04:45AM	Jim Cramer Calls Royalty Pharma (RPRX) Disappointing But Recommends Holding I Want You To Stick With It (Insider Monkey)
Dec-19-24 08:06PM	Lightning Round: MandT Bank is a buy, I like the banks, says Jim Cramer (CNBC TV)
Nov-27-24 04:15PM	Royalty Pharma to Present at Upcoming Investor Conferences (GlobeNewswire)
11:11AM	Why Royalty Pharma (RPRX) is the Cheapest Stock to Buy on Robinhood? (Insider Monkey)
Nov-14-24 04:30PM	Royalty Pharma Announces Inaugural Prize for Impact in Healthcare (GlobeNewswire)
Nov-07-24 07:10AM	Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million (GlobeNewswire)
02:10AM	Royalty Pharma PLC (RPRX) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic Acquisitions (GuruFocus.com)
12:08AM	Royalty Pharma PLC (RPRX): A Strategic SWOT Insight (GuruFocus.com)
Nov-06-24 07:16PM	Analyst Report: Royalty Pharma plc (Morningstar Research)
07:15AM	Royalty Pharma Reports Third Quarter 2024 Results (GlobeNewswire)
Nov-04-24 04:15PM	Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo (GlobeNewswire)
04:01PM	Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo (PR Newswire)
Nov-03-24 06:11AM	Morgan Stanley Predicts Up to 670% Jump for These 2 Strong Buy Stocks (TipRanks)

Royalty Pharma Plc engages in the provision of drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta, Vertex's Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Norden Gregory	Director	Aug 11 '25	Sale	36.23	33,500	1,213,749	194,848	Aug 11 04:35 PM
Norden Gregory	Director	Aug 11 '25	Proposed Sale	36.23	33,500	1,213,747		Aug 11 04:18 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RPRX

Royalty Pharma plc

Upgrade your FINVIZ experience